. @d-kirschenbaum.bsky.social @lenakutscher.bsky.social @scherermich.bsky.social

We have been awarded an ERC Starting Grant! What for? Immune cells change their state fast in vivo — after entering a tumor they lose their anti-cancer function within hours-->see www.cell.com/cell/fulltex... <--The ERC project “VideoTranscriptomics” asks what happens in those first hours. 🧵

Thank you for all the support @dkfz.bsky.social !

Deutsches Krebsforschungszentrum (DKFZ)@dkfz.bsky.social · 9mo ago

Daniel Kirschenbaum vom DKFZ entwickelt neue Methoden um herauszufinden, wie genau Immunzellen durch bösartige Hirntumoren ausgebremst werden. Dabei fördern ihn die EACR-Mark Foundation und die Pezcoller Foundation mit dem hochdotierten Rising Star Award. @d-kirschenbaum.bsky.social t1p.de/nmz9f

Thank you for this prestigious recognition and support!

EACR - European Association for Cancer Research@helloeacr.bsky.social · 9mo ago

Join us in congratulating Daniel Kirschenbaum (University Hospital Zurich and @dkfz.bsky.social) on being selected as the recipient of the 2026 EACR - @themarkfdn.bsky.social - Pezcoller Foundation Rising Star Award! 🌟 Learn more about Daniel and the award: magazine.eacr.org/daniel-kirsc...

Honored to receive the EACR Rising Star Award 2026. Thanks to @helloeacr.bsky.social, @themarkfdn.bsky.social, and the Pezcoller Foundation for the support. This backs a vision we deeply believe in: time-resolved dynamics are key in cancer–immune interactions. tinyurl.com/45vpm3rr

Daniel Kirschenbaum receives the 2026 EACR-Mark Foundation-Pezcoller Foundation Rising Star Award - The Cancer Researcher

We are pleased to announce that Daniel Kirschenbaum has been selected as the recipient of the 2026 EACR-Mark Foundation-Pezcoller Foundation Rising Star Award. Established in 2023, this prestigious aw...

tinyurl.com